Artelo Biosciences, Inc. (ARTL) Press Releases https://ir.artelobio.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/artelobio/files/theme/images/logo-sm.png Artelo Biosciences, Inc. Logo Equisolve Investor Relations Suite <![CDATA[Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury]]> https://ir.artelobio.com/news-events/press-releases/detail/191/artelo-biosciences-announces-new-data-supporting-art26-12 Wed, 01 Jul 26 08:42:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/191/artelo-biosciences-announces-new-data-supporting-art26-12 <![CDATA[Artelo Biosciences Presents Evidence for a Common Lipid-Signaling Link Across Multiple Potential Indications for Its FABP5 Inhibitor Platform at ICRS 2026]]> https://ir.artelobio.com/news-events/press-releases/detail/190/artelo-biosciences-presents-evidence-for-a-common Tue, 30 Jun 26 08:57:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/190/artelo-biosciences-presents-evidence-for-a-common <![CDATA[Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026]]> https://ir.artelobio.com/news-events/press-releases/detail/189/artelo-biosciences-presents-clinical-and-biomarker-data Mon, 29 Jun 26 08:45:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/189/artelo-biosciences-presents-clinical-and-biomarker-data <![CDATA[Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success]]> https://ir.artelobio.com/news-events/press-releases/detail/188/artelo-biosciences-presents-art26-12-human-metabolite-data Wed, 10 Jun 26 07:38:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/188/artelo-biosciences-presents-art26-12-human-metabolite-data <![CDATA[Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results]]> https://ir.artelobio.com/news-events/press-releases/detail/187/artelo-biosciences-provides-business-update-outlining Thu, 14 May 26 16:05:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/187/artelo-biosciences-provides-business-update-outlining <![CDATA[Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development]]> https://ir.artelobio.com/news-events/press-releases/detail/186/artelo-biosciences-announces-strategic-collaboration-with Tue, 28 Apr 26 08:25:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/186/artelo-biosciences-announces-strategic-collaboration-with <![CDATA[Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile]]> https://ir.artelobio.com/news-events/press-releases/detail/185/artelo-announces-peer-reviewed-publication-supporting-its Mon, 20 Apr 26 07:50:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/185/artelo-announces-peer-reviewed-publication-supporting-its <![CDATA[Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements]]> https://ir.artelobio.com/news-events/press-releases/detail/184/artelo-biosciences-regains-compliance-with-nasdaq-listing Tue, 07 Apr 26 07:50:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/184/artelo-biosciences-regains-compliance-with-nasdaq-listing <![CDATA[Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules]]> https://ir.artelobio.com/news-events/press-releases/detail/183/artelo-biosciences-announces-closing-of-11-0-million Mon, 30 Mar 26 16:46:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/183/artelo-biosciences-announces-closing-of-11-0-million <![CDATA[Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules]]> https://ir.artelobio.com/news-events/press-releases/detail/182/artelo-biosciences-announces-11-0-million-private Fri, 27 Mar 26 10:40:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/182/artelo-biosciences-announces-11-0-million-private